The controversy began with a series of three studies pointing to ITSN1 as a Parkinson’s disease susceptibility gene. Loss-of-function variants are mutations that disable a gene’s protein product, and when such variants occur in ITSN1, the resulting condition is predicted to be haploinsufficiency: having only one working copy of the gene is not enough for normal cellular function. The most recent and most compelling piece of evidence came from Ganoza and colleagues, who screened the Rostock International Parkinson’s Disease study, known as ROPAD, a cohort that includes 8,660 participants with Parkinson’s disease. Their analysis globally replicated the earlier findings and established that ITSN1 loss-of-function carriers represent roughly one to two individuals per thousand with Parkinson’s disease suspected of having a genetic cause.

The scale of the risk elevation is what makes ITSN1 so remarkable. According to the reply, a carrier of an ITSN1 loss-of-function variant faces between five and fifteen times the risk of developing Parkinson’s disease compared with a non-carrier. That places ITSN1 among the strongest genetic risk factors identified for the condition, in a category typically reserved for well-known genes such as LRRK2 and GBA1. Equally notable is the clinical picture: the Parkinson’s disease that emerges in ITSN1 carriers does not differ significantly from classical, non-genetic Parkinson’s disease, meaning carriers present with the familiar motor syndrome rather than an exotic or easily distinguishable variant of the illness.

The Paris team had approached the gene from a different angle. After identifying three pedigrees with ITSN1 loss-of-function variants in their own cohort at the Paris Brain Institute, two of which showed positive segregation of the variant with disease across generations, they hypothesized that ITSN1 might act as a Mendelian gene. In genetics, a Mendelian gene is one in which a single mutation is sufficient to cause disease in a predictable inheritance pattern, typically autosomal dominant or recessive, as opposed to risk genes that merely shift probabilities. If ITSN1 were Mendelian, families carrying one mutation would show the disease appearing in multiple relatives in an orderly pattern, and genetic counseling would follow established rules for dominant disorders.

Ganoza and colleagues tested this hypothesis using the ROPAD data and found it wanting. The frequency of positive family history among ITSN1-associated Parkinson’s disease individuals did not differ significantly from that of individuals without ITSN1 loss-of-function variants: 23 percent versus 34 percent, a difference that failed to reach statistical significance with a p-value of 0.5. On its face, this argues against a straightforward Mendelian model, since a true dominant gene should produce a conspicuously elevated rate of affected relatives. But the Paris group, in their reply, argues that the comparison is less conclusive than it appears, and they raise two methodological concerns that deserve careful attention from anyone following the genetics of neurodegenerative disease.

The first concern involves the composition of the ROPAD cohort itself. The Paris researchers noticed that the frequency of positive family history among non-carriers, 34 percent, seems higher than what would be expected for classical Parkinson’s disease in the general population. The likely explanation, they suggest, is recruitment bias: the cohort was enriched for individuals already suspected of having a genetic etiology for their disease. The authors of the original analysis acknowledged as much, noting that the early average age at onset in their cohort, 55 years, supports the presence of such a bias. Age at onset is a classic marker in Parkinson’s genetics, since earlier-onset disease is more often genetically driven, and a cohort selected for early onset will naturally over-represent familial cases on both sides of any genetic comparison.

The second concern is more fundamental: the ROPAD analysis did not provide pedigrees, or familial structures, for the 13 individuals carrying ITSN1 loss-of-function variants. Without those family trees, the field cannot know how many relatives were actually affected in individuals reporting a positive family history, whether the inheritance pattern suggested autosomal dominance or recessivity, or whether segregation analysis was performed to confirm that the variant tracked with disease. The Paris team offers a plausible alternative explanation for the negative result: several of the loss-of-function variants may have arisen de novo, meaning spontaneously in the carrier rather than being inherited, which would explain why family history was not always positive. There is also growing evidence of reduced penetrance for ITSN1, meaning that not everyone who carries a damaging variant develops disease. Sorting out these possibilities, the reply argues, will be essential before any conclusion can be drawn about the Mendelian hypothesis, and before accurate genetic counseling can be offered to carriers and their relatives.

The counseling challenge is compounded by a feature that makes ITSN1 genuinely unusual among Parkinson’s genes. Loss-of-function variants in ITSN1 are associated not only with Parkinson’s disease but also with neurodevelopmental disorders, conditions that manifest in infancy or childhood. Other recently discovered genes, such as PSMF1 and EPG5, similarly produce a clinical spectrum running from early-onset neurodevelopmental disorders to later-onset Parkinsonism, but in those cases the type of variant usually differs, with truncating variants producing more severe phenotypic consequences than missense variants, which change only a single amino acid. For ITSN1, by contrast, only loss-of-function variants have been reported in Parkinson’s disease, and all are predicted to cause haploinsufficiency. That raises a puzzle the reply states plainly: why could the same mechanism, the loss of one functional copy of the gene, lead to two such distinct phenotypes, a childhood neurodevelopmental disorder in some carriers and a late-life neurodegenerative disease in others?

One hypothesis involves the protein itself. Two isoforms of the ITSN1 protein product, Intersectin-1, are currently known, and the location of a loss-of-function variant, whether it disrupts one isoform or both, could in principle explain the variable expressivity. However, the reply notes that variants identified in both diseases appear to affect both isoforms, so this explanation alone does not suffice, and, as Ganoza and colleagues hypothesized, other modifying factors remain to be discovered. The Paris team sketches several research strategies to find them. Functional studies using biological materials from ITSN1 loss-of-function carriers are already underway to clarify why the loss of Intersectin-1 predisposes to Parkinson’s disease, a question that persists even though the protein’s many roles, particularly as a scaffold for membrane-associated processes such as endocytosis, have been extensively characterized. A second approach would leverage large Parkinson’s disease datasets to compare genetic variant frequencies, environmental exposures, and lifestyle habits between unaffected elderly controls and carriers, with particular attention to ITSN2, the gene encoding the second member of the intersectin family, whose protein can compensate for some defects caused by reduced ITSN1 expression. The consistency of the average age at onset across studies should help researchers choose an appropriate inclusion age for controls. Beyond loss-of-function variants, certain missense variants in the missense-constrained region of the gene, spanning amino acids 1199 to 1722, have been linked to neurodevelopmental disorders, and their possible role in Parkinson’s disease has not yet been explored.

Why does this academic debate matter beyond the laboratory? The reply closes with a warning about clinical practice. Genetic testing is becoming more accessible, and ITSN1 loss-of-function variants are not so rare, so they will increasingly surface as incidental findings in people tested for unrelated reasons. For a neurologically unaffected adult, the counseling challenge resembles that of a pathogenic LRRK2 or severe GBA1 variant, both of which carry elevated risk with incomplete penetrance. But prenatal detection is a different matter entirely. A carrier fetus could face a neurodevelopmental disorder, Parkinson’s disease in later life, or possibly no ITSN1-related neurological disorder at all, a range of outcomes so wide and so uncertain that it could make decisions about pregnancy continuation agonizing for prospective parents. Having confirmed the association between ITSN1 and Parkinson’s disease through the ROPAD replication, the Paris team argues that the field now faces an urgent need to resolve the questions of penetrance, expressivity, and inheritance pattern, not only to advance the science of neurodegeneration but to give families the accurate, honest information they will inevitably demand as this gene enters routine clinical testing.

Subject of Research: Association between ITSN1 loss-of-function variants and Parkinson's disease risk and inheritance

Article Title: Reply to: Data from the ROPAD study corroborate an association between ITSN1 loss-of-function variants and Parkinson’s disease

Article References: Cogan, G., Tesson, C., Welment, L., Clot, F., LeGuern, E., Lanore, A., Dürr, A., Cormier-Dequaire, F., Debilly, B., Planes, M., Mangone, G., Lesage, S., & Brice, A. (2026). Reply to: Data from the ROPAD study corroborate an association between ITSN1 loss-of-function variants and Parkinson’s disease. npj Parkinson's Disease, 12(1), Article 236. https://doi.org/10.1038/s41531-026-01470-0

Image Credits: AI Generated

DOI: 10.1038/s41531-026-01470-0

Keywords: Parkinson's disease, ITSN1, genetics, loss-of-function variants, ROPAD study, haploinsufficiency, neurodevelopmental disorders, genetic counseling, reduced penetrance, Mendelian inheritance, LRRK2, GBA1

The underlying genetics of CMS in pepper are deceptively simple in outline. Sterility arises when S-type cytoplasm, housed in the mitochondria and inherited only through the female parent, is combined with recessive nuclear alleles at the fertility-restorer locus. Plants carrying sterile cytoplasm and the recessive rfrf nuclear genotype are male sterile; introducing the dominant Rf gene restores pollen production. A maintainer line, which carries normal N cytoplasm with recessive nuclear alleles, allows breeders to propagate the sterile line indefinitely. In practice, however, the system has been notoriously unstable. Fertility restoration in many pepper backgrounds is influenced by modifier genes and by environmental conditions, particularly temperature, so plants classified as restorers sometimes shed sterile pollen, undermining seed purity and yield in commercial hybrid seed fields.

CMS in pepper has a long history. It was first documented in 1958 in the Indian accession PI 164835, and subsequent decades of research have linked several mitochondrial open reading frames to the sterility phenotype. Yet most of that work focused on mapping restorer genes and developing molecular markers rather than on building a reliable pipeline for creating new sterile and restorer lines. Traditionally, breeders relied on spontaneous mutations to generate CMS material, and the dominant strategy for expanding the sterile inventory was backcrossing: transferring sterile cytoplasm into lines with different agronomic traits through repeated crossing. While that approach produced many CMS lines, the instability of corresponding restorer lines remained a stubborn bottleneck that limited the large-scale adoption of CMS-based hybrid seed production in pepper.

The new study attacks that bottleneck by constructing what the authors call an intermediate restorer line with the genotype S(RfRf) — a plant that carries sterile cytoplasm but, because it also carries the dominant restorer gene in homozygous form, is fully fertile. The raw materials came from the team’s own germplasm collection. The CMS line A2 traces to a horn-shaped landrace, 96-140, introduced in 1996 from Lanzhou in Gansu Province, in which a stably inherited male-sterile plant was identified; its maintainer B2 was selected from the same landrace. The restorer line C1 was screened in 2003 from the cultivar Nanjing Zao Jiao grown in Jiangsu Province, and its fertility restoration is governed by a single dominant gene following clean Mendelian inheritance — a property that proved central to the strategy’s success.

To build the intermediate line, the researchers crossed A2 as the female parent with C1 as the male parent. All 104 F1 plants were fertile, confirming that C1 fully restored A2’s sterility. The team then selfed the F1 and examined fertility segregation in the F2 generation: of 720 seeds sown, 716 seedlings were evaluated, yielding 557 fertile and 159 sterile plants. A chi-square test returned a value of 2.98, below the 3.84 threshold for significance at the 5 percent level, confirming segregation in the classic 3:1 ratio expected when a single dominant nuclear gene controls restoration. Ten fertile plants were retained and self-pollinated, and one descendant line, designated AC06, showed no fertility segregation and favorable agronomic performance. After advancing to the F7 generation, the line — renamed C2 — carried the 556-base-pair nuclear band diagnostic of the Rf gene and the 130-base-pair cytoplasmic band diagnostic of S cytoplasm, confirming its S(RfRf) genotype.

That genotype is the linchpin of the whole approach. Because C2 is fertile, it can be selfed and maintained like a normal line; because it carries S cytoplasm, it transmits that cytoplasm maternally when used as a female parent. The team crossed C2 with YWF, a wrinkled-fruit line with the genotype N(rfrf) that had been selected in 2010 from the cultivar Zaozhuang Yiwofeng in Shandong Province. All F1 progeny inherited S cytoplasm and were heterozygous at the restorer locus, S(Rfrf), and therefore fertile. Self-pollination produced an F2 generation in which fertility segregated, and the male-sterile plants — S(rfrf) — were maintained by pollination with YWF. Over successive generations of maintenance, the sterile progeny converged genetically toward YWF, and by the fifth generation the team had obtained CMS lines whose nuclear background was essentially that of the elite parent, but whose cytoplasm had been converted from N to S.

The same cross also regenerated restorer lines. Ten fertile F2 plants were selfed, and line YWFC10, which showed consistent fertility without segregation, was advanced through five generations of self-pollination. From this material the researchers selected five superior restorer lines, designated f14 through f18, meeting strict criteria: strong and stable restoring ability, abundant pollen production, excellent agronomic traits, and high combining ability. Meanwhile, three CMS lines — f28-A, f31-A, and f32-A — were identified on the basis of coordinated growth vigor, robust stems, reasonable branching, and plant architecture suited to good ventilation, light penetration, and convenient field operations. Genotyping confirmed that all new CMS and restorer lines carried sterile S cytoplasm, while the CMS lines carried sterile nuclear alleles and the restorer lines carried fertile ones. In effect, a complete three-line system — sterile, maintainer, and restorer — was assembled around a single elite genetic background.

Two molecular markers did the heavy lifting throughout. The CMS-SCAR(130) marker, developed by Ji and colleagues, discriminates between S- and N-type cytoplasm even though the two differ by only ten base pairs, and it has proven more reliable than previously reported CMS markers. The CRF-SCAR marker, developed by Jo and colleagues, amplifies a 556-base-pair fragment specific to restorer lines and achieved a phenotypic prediction accuracy of 89 percent across 55 pepper accessions in earlier validation. In the present study, both markers showed complete concordance with the breeding materials, allowing the team to track cytoplasmic and nuclear genotypes precisely at every generation. The researchers note that marker-assisted selection substantially reduced the land area required for transplanting and shortened the flowering period needed for evaluation, cutting costs while accelerating line conversion.

The broader implications reach beyond pepper breeding logistics. Because the intermediate S(RfRf) line can serve as a universal converter, the authors argue that CMS and restorer lines could in principle be generated for virtually any pepper type, provided the target germplasm’s nuclear genome is free of modifier genes that influence fertility. Elite commercial hybrids could be converted into CMS versions for seed production, which would lower costs and simultaneously help safeguard breeders’ intellectual property, since the sterile cytoplasm acts as a built-in genetic lock. The strategy also breaks a long-standing limitation: until now, CMS and restorer lines in pepper could essentially only be obtained through spontaneous mutations or laborious backcrossing schemes that left restorer lines genetically unstable. The single-gene nuclear inheritance of the team’s materials, combined with maternally inherited cytoplasmic factors, simplifies the incorporation of both the sterile cytoplasm and the restorer gene into elite lines, an outcome the authors align with the concept of molecular design breeding in pepper.

The researchers are candid about the approach’s constraints: breeding materials must not carry additional genes that affect fertility, and environmental influences on CMS expression remain a general challenge in the crop. Even so, the demonstration that an intermediate isocytoplasmic material can simultaneously yield stable sterile lines, matching restorer lines, and a maintainer — all verified by two robust molecular markers and segregation patterns consistent with Mendel’s first law — offers pepper breeders a scalable, resource-efficient framework. For an industry in which manual emasculation has historically consumed enormous labor and imperfect restorers have eroded seed purity, a reproducible route to customized three-line systems may prove one of the more consequential breeding advances the crop has seen in decades.

Subject of Research: Development of stable cytoplasmic male sterility and fertility restorer lines in pepper using intermediate isocytoplasmic materials and marker-assisted selection

Article Title: A novel strategy for developing CMS and restorer lines in pepper using intermediate isocytoplasmic materials

Article References: Sun, G., Zhang, C., Shan, X., Xu, D., Dai, Z., Zhang, Z., Jiang, F., & Ma, Z. (2026). A novel strategy for developing CMS and restorer lines in pepper using intermediate isocytoplasmic materials. Discover Plants, 3(1), Article 374. https://doi.org/10.1007/s44372-026-00842-3

Image Credits: AI Generated

DOI: 10.1007/s44372-026-00842-3

Keywords: cytoplasmic male sterility, Capsicum annuum, pepper breeding, restorer line, marker-assisted selection, isocytoplasmic lines, hybrid seed production, SCAR markers, fertility restoration, plant genetics, Mendelian inheritance, molecular breeding